PDB Short entry for 1IVY HEADER CARBOXYPEPTIDASE 12-JUN-96 1IVY TITLE PHYSIOLOGICAL DIMER HPP PRECURSOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMAN PROTECTIVE PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTECTIVE PROTEIN/CATHEPSIN A, CARBOXYPEPTIDASE L; COMPND 5 EC: 3.4.16.5; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: SF21; SOURCE 6 GENE: HUPP54; SOURCE 7 EXPRESSION_SYSTEM: SF21 INSECT CELLS; SOURCE 8 EXPRESSION_SYSTEM_GENE: HUPP54; SOURCE 9 OTHER_DETAILS: BACULOVIRUS MEDIATED OVER-EXPRESSION. SEE BONTEN ET SOURCE 10 AL. 1995, J.B.C. 270, P. 26441-26445 KEYWDS CARBOXYPEPTIDASE, SERINE CARBOXYPEPTIDASE, PROTECTIVE PROTEIN, KEYWDS 2 GLYCOPROTEIN, ZYMOGEN EXPDTA X-RAY DIFFRACTION AUTHOR G.RUDENKO,E.BONTEN,A.D'AZZO,W.G.J.HOL REVDAT 6 03-APR-24 1IVY 1 HETSYN REVDAT 5 29-JUL-20 1IVY 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 13-JUL-11 1IVY 1 VERSN REVDAT 3 24-FEB-09 1IVY 1 VERSN REVDAT 2 01-APR-03 1IVY 1 JRNL REVDAT 1 21-APR-97 1IVY 0 JRNL AUTH G.RUDENKO,E.BONTEN,A.D'AZZO,W.G.HOL JRNL TITL THREE-DIMENSIONAL STRUCTURE OF THE HUMAN 'PROTECTIVE JRNL TITL 2 PROTEIN': STRUCTURE OF THE PRECURSOR FORM SUGGESTS A COMPLEX JRNL TITL 3 ACTIVATION MECHANISM. JRNL REF STRUCTURE V. 3 1249 1995 JRNL REFN ISSN 0969-2126 JRNL PMID 8591035 JRNL DOI 10.1016/S0969-2126(01)00260-X REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH G.RUDENKO,E.BONTEN,A.D'AZZO,W.G.J.HOL REMARK 1 TITL STRUCTURE DETERMINATION OF THE HUMAN PROTECTIVE PROTEIN: REMARK 1 TITL 2 TWOFOLD AVERAGING REVEALS THE THREE-DIMENSIONAL STRUCTURE OF REMARK 1 TITL 3 A DOMAIN WHICH WAS ENTIRELY ABSENT IN THE INITIAL MODEL REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 52 923 1996 REMARK 1 REFN ISSN 0907-4449 REMARK 1 REFERENCE 2 REMARK 1 AUTH N.J.GALJART,N.GILLEMANS,A.HARRIS,G.T.VAN DER HORST, REMARK 1 AUTH 2 F.W.VERHEIJEN,H.GALJAARD,A.D'AZZO REMARK 1 TITL EXPRESSION OF CDNA ENCODING THE HUMAN 'PROTECTIVE PROTEIN' REMARK 1 TITL 2 ASSOCIATED WITH LYSOSOMAL BETA-GALACTOSIDASE AND REMARK 1 TITL 3 NEURAMINIDASE: HOMOLOGY TO YEAST PROTEASES REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 54 755 1988 REMARK 1 REFN ISSN 0092-8674 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 82.9 REMARK 3 NUMBER OF REFLECTIONS : 57704 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.30 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 56.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7172 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 296 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : 0.28 REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.720 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 RESIDUES ASN B 216 AND LEU B 217 ARE IN AN AREA OF POOR REMARK 3 ELECTRON DENSITY. THE EXACT GEOMETRY OF THESE RESIDUES REMARK 3 IS NOT CLEAR FROM THE ELECTRON DENSITY MAP, BUT THEIR REMARK 3 GENERAL POSITION IS. IN ADDITION, THE RESTRAINING REMARK 3 DISULFIDE CYS 213 - CYS 218 SUPPORTS THE DEPOSITORS' REMARK 3 MODEL IN THIS AREA. REMARK 4 REMARK 4 1IVY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000174285. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-MAR-94 REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : 8.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.08 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM 5.2, ROTAVATA, AGROVATA, REMARK 200 TRUNCATE REMARK 200 DATA SCALING SOFTWARE : CCP4 (AGROVATA, ROTAVATA, REMARK 200 TRUNCATE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67740 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 32.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.13000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT AND REMARK 200 TWO-FOLD AVERAGING REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: SERINE CARBOXYPEPTIDASE FROM WHEAT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, PH 8.0 - 8.3 AT 4 - 12 REMARK 280 DEGREES CELSIUS, TEMPERATURE 285K, PH 8.3 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 57.52000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 74.05500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 57.52000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 74.05500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 34600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 259 REMARK 465 HIS B 260 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 8 CG CD OE1 NE2 REMARK 470 ARG A 9 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 46 CG CD OE1 OE2 REMARK 470 ASN A 47 CG OD1 ND2 REMARK 470 PHE A 113 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 326 CG CD OE1 OE2 REMARK 470 VAL A 393 CG1 CG2 REMARK 470 GLU B 46 CG CD OE1 OE2 REMARK 470 GLN B 215 CG CD OE1 NE2 REMARK 470 LYS B 217 CG CD CE NZ REMARK 470 PHE B 261 CG CD1 CD2 CE1 CE2 CZ REMARK 470 TYR B 263 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 265 CG CD CE NZ REMARK 470 LYS B 283 CG CD CE NZ REMARK 470 LYS B 296 CG CD CE NZ REMARK 470 GLU B 326 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O TYR A 402 N ASP A 404 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLN B 215 C ASN B 216 N -0.192 REMARK 500 ASN B 216 C LYS B 217 N -0.176 REMARK 500 LYS B 217 N LYS B 217 CA 0.270 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 258 C - N - CA ANGL. DEV. = 14.4 DEGREES REMARK 500 PRO A 258 C - N - CD ANGL. DEV. = -24.2 DEGREES REMARK 500 LEU A 366 CA - CB - CG ANGL. DEV. = 15.9 DEGREES REMARK 500 ASN B 216 C - N - CA ANGL. DEV. = 28.6 DEGREES REMARK 500 LYS B 217 N - CA - CB ANGL. DEV. = -16.2 DEGREES REMARK 500 LYS B 217 N - CA - C ANGL. DEV. = 21.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 29 152.23 -43.41 REMARK 500 GLU A 69 -70.93 -114.18 REMARK 500 VAL A 80 -41.62 -134.45 REMARK 500 SER A 150 -112.00 63.84 REMARK 500 ASN A 178 55.63 38.77 REMARK 500 SER A 214 114.05 -160.66 REMARK 500 GLN A 215 -160.69 86.54 REMARK 500 ASN A 248 99.09 -164.35 REMARK 500 VAL A 257 -166.37 -102.15 REMARK 500 PRO A 258 37.48 -150.15 REMARK 500 LYS A 265 -102.48 71.99 REMARK 500 ASP A 404 53.03 21.71 REMARK 500 HIS A 418 -6.66 79.46 REMARK 500 MET A 430 73.94 -104.01 REMARK 500 SER B 29 139.74 -34.96 REMARK 500 GLU B 69 -75.71 -107.13 REMARK 500 VAL B 80 -42.43 -135.88 REMARK 500 SER B 150 -122.05 68.59 REMARK 500 ALA B 152 6.78 -68.32 REMARK 500 ASN B 178 51.58 39.24 REMARK 500 SER B 182 117.81 -161.11 REMARK 500 TYR B 221 -77.61 -90.71 REMARK 500 ASN B 241 36.88 -147.52 REMARK 500 ASN B 248 107.41 -168.42 REMARK 500 LYS B 265 95.57 70.96 REMARK 500 ASN B 376 150.44 -47.68 REMARK 500 MET B 430 76.68 -101.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN B 216 LYS B 217 124.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CATALYTIC TRIAD SERINE CARBOXYPEPTIDASE. DBREF 1IVY A 1 452 UNP P10619 PRTP_HUMAN 29 480 DBREF 1IVY B 1 452 UNP P10619 PRTP_HUMAN 29 480 SEQRES 1 A 452 ALA PRO ASP GLN ASP GLU ILE GLN ARG LEU PRO GLY LEU SEQRES 2 A 452 ALA LYS GLN PRO SER PHE ARG GLN TYR SER GLY TYR LEU SEQRES 3 A 452 LYS SER SER GLY SER LYS HIS LEU HIS TYR TRP PHE VAL SEQRES 4 A 452 GLU SER GLN LYS ASP PRO GLU ASN SER PRO VAL VAL LEU SEQRES 5 A 452 TRP LEU ASN GLY GLY PRO GLY CYS SER SER LEU ASP GLY SEQRES 6 A 452 LEU LEU THR GLU HIS GLY PRO PHE LEU VAL GLN PRO ASP SEQRES 7 A 452 GLY VAL THR LEU GLU TYR ASN PRO TYR SER TRP ASN LEU SEQRES 8 A 452 ILE ALA ASN VAL LEU TYR LEU GLU SER PRO ALA GLY VAL SEQRES 9 A 452 GLY PHE SER TYR SER ASP ASP LYS PHE TYR ALA THR ASN SEQRES 10 A 452 ASP THR GLU VAL ALA GLN SER ASN PHE GLU ALA LEU GLN SEQRES 11 A 452 ASP PHE PHE ARG LEU PHE PRO GLU TYR LYS ASN ASN LYS SEQRES 12 A 452 LEU PHE LEU THR GLY GLU SER TYR ALA GLY ILE TYR ILE SEQRES 13 A 452 PRO THR LEU ALA VAL LEU VAL MET GLN ASP PRO SER MET SEQRES 14 A 452 ASN LEU GLN GLY LEU ALA VAL GLY ASN GLY LEU SER SER SEQRES 15 A 452 TYR GLU GLN ASN ASP ASN SER LEU VAL TYR PHE ALA TYR SEQRES 16 A 452 TYR HIS GLY LEU LEU GLY ASN ARG LEU TRP SER SER LEU SEQRES 17 A 452 GLN THR HIS CYS CYS SER GLN ASN LYS CYS ASN PHE TYR SEQRES 18 A 452 ASP ASN LYS ASP LEU GLU CYS VAL THR ASN LEU GLN GLU SEQRES 19 A 452 VAL ALA ARG ILE VAL GLY ASN SER GLY LEU ASN ILE TYR SEQRES 20 A 452 ASN LEU TYR ALA PRO CYS ALA GLY GLY VAL PRO SER HIS SEQRES 21 A 452 PHE ARG TYR GLU LYS ASP THR VAL VAL VAL GLN ASP LEU SEQRES 22 A 452 GLY ASN ILE PHE THR ARG LEU PRO LEU LYS ARG MET TRP SEQRES 23 A 452 HIS GLN ALA LEU LEU ARG SER GLY ASP LYS VAL ARG MET SEQRES 24 A 452 ASP PRO PRO CYS THR ASN THR THR ALA ALA SER THR TYR SEQRES 25 A 452 LEU ASN ASN PRO TYR VAL ARG LYS ALA LEU ASN ILE PRO SEQRES 26 A 452 GLU GLN LEU PRO GLN TRP ASP MET CYS ASN PHE LEU VAL SEQRES 27 A 452 ASN LEU GLN TYR ARG ARG LEU TYR ARG SER MET ASN SER SEQRES 28 A 452 GLN TYR LEU LYS LEU LEU SER SER GLN LYS TYR GLN ILE SEQRES 29 A 452 LEU LEU TYR ASN GLY ASP VAL ASP MET ALA CYS ASN PHE SEQRES 30 A 452 MET GLY ASP GLU TRP PHE VAL ASP SER LEU ASN GLN LYS SEQRES 31 A 452 MET GLU VAL GLN ARG ARG PRO TRP LEU VAL LYS TYR GLY SEQRES 32 A 452 ASP SER GLY GLU GLN ILE ALA GLY PHE VAL LYS GLU PHE SEQRES 33 A 452 SER HIS ILE ALA PHE LEU THR ILE LYS GLY ALA GLY HIS SEQRES 34 A 452 MET VAL PRO THR ASP LYS PRO LEU ALA ALA PHE THR MET SEQRES 35 A 452 PHE SER ARG PHE LEU ASN LYS GLN PRO TYR SEQRES 1 B 452 ALA PRO ASP GLN ASP GLU ILE GLN ARG LEU PRO GLY LEU SEQRES 2 B 452 ALA LYS GLN PRO SER PHE ARG GLN TYR SER GLY TYR LEU SEQRES 3 B 452 LYS SER SER GLY SER LYS HIS LEU HIS TYR TRP PHE VAL SEQRES 4 B 452 GLU SER GLN LYS ASP PRO GLU ASN SER PRO VAL VAL LEU SEQRES 5 B 452 TRP LEU ASN GLY GLY PRO GLY CYS SER SER LEU ASP GLY SEQRES 6 B 452 LEU LEU THR GLU HIS GLY PRO PHE LEU VAL GLN PRO ASP SEQRES 7 B 452 GLY VAL THR LEU GLU TYR ASN PRO TYR SER TRP ASN LEU SEQRES 8 B 452 ILE ALA ASN VAL LEU TYR LEU GLU SER PRO ALA GLY VAL SEQRES 9 B 452 GLY PHE SER TYR SER ASP ASP LYS PHE TYR ALA THR ASN SEQRES 10 B 452 ASP THR GLU VAL ALA GLN SER ASN PHE GLU ALA LEU GLN SEQRES 11 B 452 ASP PHE PHE ARG LEU PHE PRO GLU TYR LYS ASN ASN LYS SEQRES 12 B 452 LEU PHE LEU THR GLY GLU SER TYR ALA GLY ILE TYR ILE SEQRES 13 B 452 PRO THR LEU ALA VAL LEU VAL MET GLN ASP PRO SER MET SEQRES 14 B 452 ASN LEU GLN GLY LEU ALA VAL GLY ASN GLY LEU SER SER SEQRES 15 B 452 TYR GLU GLN ASN ASP ASN SER LEU VAL TYR PHE ALA TYR SEQRES 16 B 452 TYR HIS GLY LEU LEU GLY ASN ARG LEU TRP SER SER LEU SEQRES 17 B 452 GLN THR HIS CYS CYS SER GLN ASN LYS CYS ASN PHE TYR SEQRES 18 B 452 ASP ASN LYS ASP LEU GLU CYS VAL THR ASN LEU GLN GLU SEQRES 19 B 452 VAL ALA ARG ILE VAL GLY ASN SER GLY LEU ASN ILE TYR SEQRES 20 B 452 ASN LEU TYR ALA PRO CYS ALA GLY GLY VAL PRO SER HIS SEQRES 21 B 452 PHE ARG TYR GLU LYS ASP THR VAL VAL VAL GLN ASP LEU SEQRES 22 B 452 GLY ASN ILE PHE THR ARG LEU PRO LEU LYS ARG MET TRP SEQRES 23 B 452 HIS GLN ALA LEU LEU ARG SER GLY ASP LYS VAL ARG MET SEQRES 24 B 452 ASP PRO PRO CYS THR ASN THR THR ALA ALA SER THR TYR SEQRES 25 B 452 LEU ASN ASN PRO TYR VAL ARG LYS ALA LEU ASN ILE PRO SEQRES 26 B 452 GLU GLN LEU PRO GLN TRP ASP MET CYS ASN PHE LEU VAL SEQRES 27 B 452 ASN LEU GLN TYR ARG ARG LEU TYR ARG SER MET ASN SER SEQRES 28 B 452 GLN TYR LEU LYS LEU LEU SER SER GLN LYS TYR GLN ILE SEQRES 29 B 452 LEU LEU TYR ASN GLY ASP VAL ASP MET ALA CYS ASN PHE SEQRES 30 B 452 MET GLY ASP GLU TRP PHE VAL ASP SER LEU ASN GLN LYS SEQRES 31 B 452 MET GLU VAL GLN ARG ARG PRO TRP LEU VAL LYS TYR GLY SEQRES 32 B 452 ASP SER GLY GLU GLN ILE ALA GLY PHE VAL LYS GLU PHE SEQRES 33 B 452 SER HIS ILE ALA PHE LEU THR ILE LYS GLY ALA GLY HIS SEQRES 34 B 452 MET VAL PRO THR ASP LYS PRO LEU ALA ALA PHE THR MET SEQRES 35 B 452 PHE SER ARG PHE LEU ASN LYS GLN PRO TYR MODRES 1IVY ASN A 117 ASN GLYCOSYLATION SITE MODRES 1IVY ASN A 305 ASN GLYCOSYLATION SITE MODRES 1IVY ASN B 117 ASN GLYCOSYLATION SITE MODRES 1IVY ASN B 305 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NDG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET NAG A3020 14 HET NAG B3040 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE FORMUL 3 NAG 5(C8 H15 N O6) FORMUL 3 NDG C8 H15 N O6 FORMUL 7 HOH *296(H2 O) HELIX 1 1 LEU A 63 LEU A 67 1 5 HELIX 2 2 ASP A 118 LEU A 135 1 18 HELIX 3 3 ALA A 152 VAL A 163 5 12 HELIX 4 4 TYR A 183 TYR A 196 1 14 HELIX 5 5 ASN A 202 CYS A 212 1 11 HELIX 6 6 LEU A 226 GLY A 240 1 15 HELIX 7 7 LEU A 290 SER A 293 5 4 HELIX 8 8 THR A 307 LEU A 313 1 7 HELIX 9 9 PRO A 316 ALA A 321 1 6 HELIX 10 10 PHE A 336 GLN A 341 1 6 HELIX 11 11 ASN A 350 SER A 359 1 10 HELIX 12 12 PHE A 377 SER A 386 1 10 HELIX 13 13 VAL A 431 ASP A 434 1 4 HELIX 14 14 PRO A 436 LEU A 447 1 12 HELIX 15 15 LEU B 63 LEU B 67 1 5 HELIX 16 16 ASP B 118 LEU B 135 1 18 HELIX 17 17 ALA B 152 VAL B 163 5 12 HELIX 18 18 TYR B 183 TYR B 196 1 14 HELIX 19 19 ASN B 202 CYS B 212 1 11 HELIX 20 20 LEU B 226 GLY B 240 1 15 HELIX 21 21 THR B 307 LEU B 313 1 7 HELIX 22 22 PRO B 316 ALA B 321 1 6 HELIX 23 23 PHE B 336 GLN B 341 1 6 HELIX 24 24 ASN B 350 SER B 359 1 10 HELIX 25 25 PHE B 377 SER B 386 1 10 HELIX 26 26 VAL B 431 ASP B 434 1 4 HELIX 27 27 PRO B 436 LEU B 447 1 12 SHEET 1 A10 GLN A 21 LYS A 27 0 SHEET 2 A10 LYS A 32 VAL A 39 -1 N PHE A 38 O TYR A 22 SHEET 3 A10 ASN A 94 LEU A 98 -1 N TYR A 97 O TRP A 37 SHEET 4 A10 VAL A 50 LEU A 54 1 N VAL A 51 O ASN A 94 SHEET 5 A10 LEU A 144 GLU A 149 1 N PHE A 145 O VAL A 50 SHEET 6 A10 LEU A 171 GLY A 177 1 N GLN A 172 O LEU A 144 SHEET 7 A10 GLN A 363 GLY A 369 1 N GLN A 363 O LEU A 174 SHEET 8 A10 ILE A 419 ILE A 424 1 N ALA A 420 O ILE A 364 SHEET 9 A10 GLU A 407 PHE A 416 -1 N LYS A 414 O PHE A 421 SHEET 10 A10 MET A 391 LYS A 401 -1 N VAL A 400 O GLN A 408 SHEET 1 B 2 PHE A 73 VAL A 75 0 SHEET 2 B 2 LEU A 82 TYR A 84 -1 N GLU A 83 O LEU A 74 SHEET 1 C 3 PHE A 261 GLU A 264 0 SHEET 2 C 3 THR A 267 VAL A 270 -1 N VAL A 269 O ARG A 262 SHEET 3 C 3 LYS A 296 MET A 299 1 N LYS A 296 O VAL A 268 SHEET 1 D10 GLN B 21 LYS B 27 0 SHEET 2 D10 LYS B 32 VAL B 39 -1 N PHE B 38 O TYR B 22 SHEET 3 D10 ASN B 94 LEU B 98 -1 N TYR B 97 O TRP B 37 SHEET 4 D10 VAL B 50 LEU B 54 1 N VAL B 51 O ASN B 94 SHEET 5 D10 LEU B 144 GLU B 149 1 N PHE B 145 O VAL B 50 SHEET 6 D10 LEU B 171 GLY B 177 1 N GLN B 172 O LEU B 144 SHEET 7 D10 GLN B 363 GLY B 369 1 N GLN B 363 O LEU B 174 SHEET 8 D10 ILE B 419 ILE B 424 1 N ALA B 420 O ILE B 364 SHEET 9 D10 GLU B 407 PHE B 416 -1 N PHE B 416 O ILE B 419 SHEET 10 D10 MET B 391 LYS B 401 -1 N VAL B 400 O GLN B 408 SHEET 1 E 2 PHE B 73 VAL B 75 0 SHEET 2 E 2 LEU B 82 TYR B 84 -1 N GLU B 83 O LEU B 74 SHEET 1 F 2 THR B 267 VAL B 270 0 SHEET 2 F 2 LYS B 296 MET B 299 1 N LYS B 296 O VAL B 268 SSBOND 1 CYS A 60 CYS A 334 1555 1555 2.03 SSBOND 2 CYS A 212 CYS A 228 1555 1555 2.03 SSBOND 3 CYS A 213 CYS A 218 1555 1555 2.01 SSBOND 4 CYS A 253 CYS A 303 1555 1555 2.02 SSBOND 5 CYS B 60 CYS B 334 1555 1555 2.05 SSBOND 6 CYS B 212 CYS B 228 1555 1555 2.05 SSBOND 7 CYS B 213 CYS B 218 1555 1555 2.02 SSBOND 8 CYS B 253 CYS B 303 1555 1555 2.03 LINK ND2 ASN A 117 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN A 305 C1 NAG A3020 1555 1555 1.44 LINK ND2 ASN B 117 C1 NAG D 1 1555 1555 1.45 LINK ND2 ASN B 305 C1 NAG B3040 1555 1555 1.44 LINK O4 NAG C 1 C1 NDG C 2 1555 1555 1.39 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.39 CISPEP 1 GLY A 57 PRO A 58 0 1.29 CISPEP 2 SER A 100 PRO A 101 0 0.52 CISPEP 3 GLY B 57 PRO B 58 0 -0.46 CISPEP 4 SER B 100 PRO B 101 0 -0.63 SITE 1 CAT 6 SER A 150 ASP A 372 HIS A 429 SER B 150 SITE 2 CAT 6 ASP B 372 HIS B 429 CRYST1 115.040 148.110 80.970 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008693 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006752 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012350 0.00000